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Abstract
Background: Few studies focused on the study of blood groups in Gabon. This study
aimed to determine the phenotypic frequency of ABO and Rhesus antigens in blood
donors of Libreville and to assess the association between ABO blood groups and
transfusion-transmitted infections.
Materials and Methods: The study of ABO and Rhesus blood groups concerned
4,744 blood donors. ABO and Rhesus phenotyping were obtained using monoclonal
monospecific antisera: anti-A, anti-B, anti-AB, anti-D, anti-E, anti-C, anti-c, and anti-e
with an automate (QWALYS® 3, DIAGAST, France) or a card gel (ID Card, BIO-RAD)
according to manufacturer’s instructions.
Results: The phenotypic frequency of blood group antigens A, B, AB and O
were respectively 21.0%; 17.6%; 2.6% and 58.9%. Those of Rhesus antigens D,
d, C, c, E and e were 97.7%; 2.3%; 15.9%; 99.9%; 17.6%; 99.3%, respectively.
The prevalence of ABO and Rh antigens in Gabonese donors reported here are
significantly different from those of neighboring countries. No association was found
between the prevalence of HIV, HCV and syphilis and ABO blood groups. Instead, HBV
seroprevalence was twice as high among non-O blood groups donors compared with
blood group O donors [OR = 2 (CI 1.26 to 3.2), p = 0.003].
Conclusions: This study provides new data on phenotypic frequency of ABO and Rh
blood groups in a representative sample of the Gabonese blood donor population. It
suggests a significant association between ABO blood group and HBV infection.
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1. INTRODUCTION
Blood transfusion remains a therapy carrying specific risks not only because of the
possible blood incompatibility between the donor and the recipient; but also because
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of the potential transmission of blood borne pathogens. One of the ways to limit
the post-transfusion adverse events is to phenotype blood donors for the main red
cell blood group systems and to simultaneously detect the transfusion-transmitted
infections (TTIs).
According to the WHO, in 39 countries blood donations are still not routinely tested
for TTIs including HIV, HBV, HCV and syphilis; 47% of blood bags in low-income coun-
tries are examined in laboratories without quality assurance [1]. It is estimated that
1.6 million blood units/year are deferred and destroyed due to the presence of TTI’s
markers [1].
The understanding of blood group systems has evolved to include not only blood
transfusion compatibility but also the relationship between some infectious diseases
and the antigens in erythrocytes [2]. Several studies have shown an association
between specific blood group antigens and the risk of pancreatic cancer [3–5]. Asso-
ciations between the ABO system and various diseases including malaria infection,
cerebral thrombosis and ovarian cancer have also been found [6–8].
In Gabon, few studies have been devoted to blood groups. This relative lack of infor-
mation has led to undertaking this study. This investigation aimed to determine the
phenotypic frequencies of the ABO and Rhesus D, C, c, E, e antigens in the Gabonese
population and to study the association between transfusion-transmitted infections
and the ABO blood groups.
2. MATERIALS AND METHODS
2.1. Blood donors
A retrospective analysis of blood donors’ data from January to May 2015 in the
national blood transfusion center (CNTS) in Libreville, Gabon was conducted. Volunteer
and family/replacement donors were all apparently healthy subjects, selected after
responding to a questionnaire including a medical history. They were aged 17–65 years
weighing over 50 kg and eligible for blood donation. Socio-demographic characteristics
were recorded, and venous blood was collected in blood collection bags following
standard procedures.
2.2. Determination of ABO and Rh phenotyping
ABO and Rhesus phenotyping were obtained using monoclonal monospecific antis-
era: anti-A, anti-B, anti-AB, anti-D, anti-E, anti-C, anti-c, and anti-e with an automate
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(QWALYS® 3, DIAGAST, France) or a card gel (ID Card, BIO-RAD) according to manufac-
turer’s instructions. Positive and negative control red cells were used and the Beth-
Vincent and Simonin-Michon’s tests were performed as controls.
2.3. Serological analysis
Antibodies to HCV and HIV types 1 and 2 were detected using Monolisa HCV Ag-
Ab ULTRA version 2 and Genscreen HIV-1/2 version 2 (BIO-RAD, Marnes-la-coquette,
France). Hepatitis B surface antigen (HBsAg) and antibodies to Treponema pallidum
were screened with Monolisa HBsAg ULTRA and Treponema pallidum haemagglu-
tination test (BIO-RAD, Marnes-la-coquette, France) following the manufacturer’s
instructions.
2.4. Statistical analysis
Data analysis was done by using the Statistical Package for the Social Sciences (SPSS
version 20.0) and EPI-Info version 6.04dfr (CDC, Atlanta, USA). The results were con-
sidered significant for P < 0.05.
3. RESULTS
3.1. ABO and Rh phenotypic frequencies
From a total of 4,744 blood donors, 59.7% were in the age group of 21-30 years with
a mean age of 29.9 ± 7.0 (range 17-61 years). Of these, 83.1% donors were male and
16.9% donors were female.
Among blood donors the overall prevalence of blood groups O, A, B and AB were
58.9%; 21.0%; 17.6% and 2.6%, respectively (Table 1). The majority of blood donors
from O blood group were male (48.8%). AB blood group was the least represented
among blood donors (2.2% of male and 0.4% of female) (Table 1).
In the Rhesus blood group, 5 antigens were tested: D (RH1), C (RH2), E (RH3), c (RH4)
and e (RH5). The absence of the D antigen was denoted d (Rhesus negative). The
frequencies of Rhesus antigens D, d, C, E, c and e were respectively 97.7%; 2.3%;
15.9%; 17.6%; 99.9% and 99.3% (Table 2). The majority of Rhesus negative individuals
was male (2.0%) and from O blood group (1.4%). Only 0.3% of female was Rhesus
negative and 0.1% of blood donors were both AB blood group and Rhesus negative
(Table 2).
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Blood Groups
O A B AB
N (%) N (%) N (%) N (%)
Sex
Male 2,314 (48.8) 832 (17.5) 692 (14.6) 105 (2.2)
Female 478 (10.1) 162 (3.4) 144 (3.0) 17 (0.4)
Age groups (years)
≤ 20 88 (1.9) 29 (0.6) 29 (0.6) 5 (0.1)
21-30 1,658 (35.0) 597 (12.6) 507 (10.7) 71 (1.5)
31-40 775 (16.3) 276 (5.8) 221 (4.7) 38 (0.8)
> 40 271 (5.7) 92 (1.9) 79 (1.7) 8 (0.2)
Total 2,792 (58.9) 994 (21.0) 836 (17.6) 122 (2.6)
T 1: Frequency of ABO blood groups in blood donors according to sex and age groups.
The major Rh phenotypes observed among blood donors were respectively Dccee
(66.5%), DccEe (15.3%) and DCcee (13.5%). The minor phenotypes obtained were
DCcEe (1.5%), ddccee (1.5%), dCcee (0.8%), DccEE (0.7%), DCCee (0.1%) and DCCEe
(0.02%).
3.2. Association between blood groups and
transfusion-transmitted infections
Among blood donors 233/4,744 (4.9%) were infected with at least one pathogen. The
overall seroprevalence of antibodies to HIV, HCV and syphilis was 1.1%; 0.5% and 1.6%;
HBsAg prevalence was 1.7%. The seroprevalence of HIV, HBV, HCV and syphilis markers
was compared between blood donors of blood group O and non-O as shown in Table
3.
HIV, HCV and syphilis markers seroprevalence was similar in blood donors of group
O compared to non-O blood groups (Table 3). However, the prevalence of HBsAg was
twice higher among non-O blood groups donors compared to donors of O blood group
[OR= 2; 95%CI: 1.3, 3.2; p = 0.003].
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Sex Blood groups
Male Female O A B AB
Rh
antigens





972 (20.5%) 818 (17.2%) 117 (2.5%)
d 97 (2.0%) 14 (0.3%) 66 (1.4%) 22 (0.5%) 18 (0.4%) 5 (0.1%)





994 (21.0%) 835 (17.6%) 122 (2.6%)





991 (20. 9%) 828 (17.5%) 121 (2.6%)
T 2: Distribution of rhesus antigens according to sex and blood groups.
Blood groups N HIV positive N (%) OR (IC 95%) P-values
O 2,792 29 (1.0) - 0.635
Non O 1,952 24 (1.2) 1.2 (0. 7-2.1)
HBV positive N (%)
O 2,792 34 (1.2) - 0.003
Non O 1,952 47 (2.4) 2 (1.3-3.2)
HCV positive N (%)
O 2,792 10 (0.4) - 0.288
Non O 1,952 12 (0.6) 1.7 (0.7-4.3)
Syphilis positive N (%)
O 2,792 44 (1.6) - 0.848
Non O 1,952 33 (1.7%) 1.1 (0.7-1.7)
OR= Odds ratio ; CI = confidence interval. In bold significant p-value
T 3: Prevalence of HIV, HBV, HCV and syphilis according to ABO blood groups.
4. DISCUSSION
This study aimed to determine the prevalence of ABO and Rhesus blood groups among
blood donors and their association with TTIs. This study shows the distribution of ABO
and Rhesus phenotypes in a relatively large population of Gabonese blood donors.
The phenotypic frequency of blood groups A, B, AB, O and D were respectively 21.0%,
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Continents/countries Frequencies of ABO and RhD (%) References
O A B AB D
Present study (N= 4,744) 58.9 21.0 17.6 2.6 97.7
Africa
Congo (N= 5,400) 52.3 23.1 21.1 3.5 Ref. [13]
Cameroon (N= 14,546) 48.6 25.1 21.9 4.5 96.3 Ref. [14]
Burkina Faso (N= 37,210) 43.4 22.7 28.2 5.8 86.2 Ref. [15]
Morocco (N= 344,954) 46.1 33.9 15.7 4.3 Ref. [16]
Europe
France 43.0 45.0 9.0 3.0 85.0 Ref. [17]
Asia
India (N = 12,701) 28.7 28.7 32.1 10.5 94.5 Ref. [8]
Japon 29.9 39.8 19.9 9.9 - Ref. [19]
USA 46.6 37.1 12.2 4.1 85.4 Ref. [20]
T 4: Comparison of ABO frequency in Gabonese blood donors and in previous studies.
17.6%, 2.6%, 58.9 and 97.7% (Tables 1 and 2). Group O and Rh positive blood groups
were predominant in contrast with AB and Rh negative groups. The AB blood group
was relatively rare, (0.4% in women and 2.2% in men). There were very few Rh neg-
ative women (0.3%) limiting the risk of maternal-fetal incompatibility and its preven-
tion during pregnancy. The major Rhesus phenotypes observed were Dccee (66.5%),
DccEe (15.3%), DCcee (13.5%). Indeed, Dccee Rhesus phenotype has been previously
described as more prevalent in black populations9. The frequency of Dccee phenotype
found in our study is comparable to that reported in Mali10. However, it is lower than
the 73.6% reported in southern Nigeria [11].
The prevalence of the ABO blood groups were compared with those obtained in a
previous study in Gabon, which reported the following phenotypic frequencies: 20%
for A, 17.3% for B, 4.1% for AB and 58.6% for group O [12]. These results are similar to
ours presented here.
However, AB blood group prevalence was higher in the study by Languillat et al [12],
although the difference observed was not statistically significant (X2 = 2.4, p = 0.122).
Frequencies of the ABO and Rh blood groups obtained from blood donors were com-
pared to neighboring donor populations of Central Africa (Congo and Cameroon), West
Africa (Burkina Faso), North Africa (Morocco) and the world (Table 4). The prevalence
of ABO phenotypes in Gabon was significantly different from those observed in other
African countries such as Congo, Cameroon, Burkina Faso, and Morocco [13–16]. In fact,
the frequency of the O blood group was higher than that observed in these African
countries while the prevalence of blood groups A and B was lower. Unsurprisingly, the
ABO phenotypic prevalences in this study were very different from those observed in
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Asia, including India and Japan; in Europe and the USA [17–20]. This could be explained
by the genetic distance between the predominantly Gabonese black population and
population of Caucasian and Asian descent. The high prevalence of group O in sub-
Saharan Africa has been in part attributed to selection related to malaria being less
severe clinically in carriers of O blood group [21–23].
This study also evaluated the association between ABO blood groups and blood-
borne infections such as HIV, HBV, HCV and syphilis. The prevalence of seroreactive
HIV, HBV, HCV and syphilis markers was 1.1%, 1.7%, 0.5% and 1.6%, respectively.
These seroprevalences were lower than seroreactivities reported in a previous study
[24]. No confirmation was performed so that the prevalence of antibodies to HIV, HCV
and syphilis was likely considerably overestimated. The difference between the two
sample sizes, the selection of Gabonese donors only in the present study and the
evolution of these infections’ epidemiology could partly explain these differences.
No significant association between HIV, HCV, syphilis and ABO blood groups was
found among blood donors. However, the risk of HBV infection appeared twice higher
among non- O donors compared to O blood group donors. This result would need to be
supported by detection of HBV DNA with a sensitive assay. It is however in agreement
with previous studies [25, 26]. A recent study showed a higher risk of hepatocellular
carcinoma associatedwith hepatitis B in non-O blood group compared to O blood group
patients [27].
5. CONCLUSION
This study reports the prevalence of the ABO and RhD blood groups in a representa-
tive sample of the Gabonese blood donor population. It also suggests the association
between the ABO blood group and chronic HBV infection.
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